Company news

Abbott Laboratories (NYSE:ABT) news

Abbott Laboratories news releases on 6ix. Latest, Oct 5, 2026: Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients…

Abbott Laboratories (NYSE:ABT) news

Press releases & updates

Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

Abbott Laboratories : Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications

Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health

Abbott declares 411th consecutive quarterly dividend

First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care

Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall

Abbott and Sengkang General Hospital expand partnership to advance early detection of muscle loss and support healthy aging

Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms

Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula

Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke

Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician

Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants

Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

Abbott hosts conference call for second-quarter earnings

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

Abbott declares 410th consecutive quarterly dividend

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo

Abbott, Stringham & Lynch Announces Acquisition of Finance and Accounting Solutions Firm, ArightCo

Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche

Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor

GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market Insights

Abbott Laboratories : to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Illinois Jury Awards Four Families $70 Million in Verdict Against Baby Formula Manufacturer

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Global Medical Nutrition Market to Reach USD 31.1 Billion by 2035, Driven by Preventive Healthcare Across North America, Europe & Asia-Pacific - Key Players Nestlé, Abbott, Danone & DSM Lead Innovation

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Global Fertility Test Kits Market Grows as At-Home Diagnostics Rise, Led by Abbott, Clearblue

Abbott hosts conference call for first-quarter earnings

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening